Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Bone loss frequently appears in the natural history of liver disease. The effects of therapy for osteoporosis associated with cirrhosis of the liver are still controversial. We evaluated the effects of vitamin K2 on osteopenia in women with cirrhosis. METHODS: The subjects were 50 women with cirrhosis who had underlying hepatitis viral infections. Half of the patients were randomly assigned to receive vitamin K2 (menatetrenone). The bone mineral density (BMD) of the lumbar vertebrae was measured by dual-energy X-ray absorptiometry at entry and at 1-yr intervals for 2 yr. RESULTS: The percentages of change from the initial BMD at 1 and 2 yr after initiation of the study were, respectively, +0.1 +/- 2.6% and -0.5 +/- 3.5% for the vitamin K2-treated group and -2.2 +/- 2.4% and -4.6 +/- 3.9% for the control group. The changes in BMD at each timepoint differed significantly between the control and treated groups (p = 0.008 for 1 yr and p = 0.002 for 2 yr). In the vitamin K2-treated group, the ratio of osteocalcin to undercarboxylated osteocalcin in those patients with increases in BMD after 1 yr of treatment was significantly lower than that in patients showing decreases in BMD (p = 0.017). No adverse effects of vitamin K2 were noted. CONCLUSIONS: Vitamin K2 can prevent bone loss and may therefore be useful in the management of bone disease in women with cirrhosis of the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture
Hodges, S. J., Akesson, K., Vergnaud, P., Obrant, K., & Prof. Delmas, P. D. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081012 · Cited by 202
Calcitriol for bone disease in patients with cirrhosis of the liver
Shiomi, S., Masaki, K., Habu, D., Takeda, T., Nishiguchi, S., Kuroki, T., Tanaka, T., & Ochi, H. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01913.x · Cited by 47
Self-citation
Cited by
Emaus, N., Gjesdal, C. G., Almås, B., Christensen, M., Grimsgaard, A. S., Berntsen, G. K. R., Salomonsen, L., & Fønnebø, V. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1126-4 · Cited by 102
Osteoporosis in liver diseases and after liver transplantation
Hay, J. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00143-0 · Cited by 72
“Vitamin K therapy prevented bone loss in cirrhotic females with viral hepatitis ([23], #353) but the mechanism of this beneficial effect is unknown.”
BackgroundEmaus, N., Nguyen, N. D., Almaas, B., Berntsen, G. K., Center, J. R., Christensen, M., Gjesdal, C. G., Grimsgaard, A. S., Nguyen, T. V., Salomonsen, L., et al. (2013) · European Journal of Nutrition · doi:10.1007/s00394-011-0285-1 · Cited by 15
Metadata
- Authors
- Shiomi, S.
- Venue
- The American Journal of Gastroenterology
- Published
- 2002-04
- Volume
- 97
- Issue
- 4
- Pages
- 978-981
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2004779714
- Cited by
- 43
- References
- 2
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver. https://app.cochat.ai/papers/10.1016/s0002-9270(02)03974-6
- The paper
- Shiomi, S. (2002). Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver. The American Journal of Gastroenterology. https://doi.org/10.1016/s0002-9270(02)03974-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.